Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 173,200 | 169,038 | 169,194 | 173,207 | 182,146 |
| Cost of Goods | 125,996 | 124,451 | 127,383 | 125,694 | 128,179 |
| Gross Profit | 47,204 | 44,587 | 41,811 | 47,513 | 53,967 |
| Operating Expenses | 16,993 | 17,030 | 25,780 | 30,229 | 19,267 |
| Operating Income | 31,207 | 28,008 | 16,414 | 17,978 | 34,879 |
| Interest Expense | 3,662 | 3,714 | 3,726 | 3,634 | 3,278 |
| Pre-tax Income | 27,545 | 24,294 | 12,688 | 14,344 | 31,601 |
| Income Tax | 3,335 | 4,808 | -27,610 | 5,750 | 9,404 |
| Net Income Continuous | 24,210 | 19,486 | 40,298 | 8,594 | 22,197 |
| Net Income Discontinuous | -397 | 7,971 | 259 | 408 | 208 |
| Minority Interests | 84 | 43 | 47 | 167 | -7 |
| Net Income | $23,729 | $27,414 | $40,510 | $8,835 | $22,412 |
| EPS Basic Total Ops | 0.53 | 0.62 | 0.91 | 0.20 | 0.51 |
| EPS Basic Continuous Ops | 0.55 | 0.44 | 0.91 | 0.20 | 0.50 |
| EPS Basic Discontinuous Ops | -0.01 | 0.18 | 0.01 | N/A | 0.01 |
| EPS Diluted Total Ops | 0.53 | 0.61 | 0.91 | 0.20 | 0.50 |
| EPS Diluted Continuous Ops | 0.54 | 0.43 | 0.90 | 0.19 | 0.50 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.18 | 0.01 | 0.01 | 0.00 |
| EBITDA(a) | $36,904 | $33,794 | $22,001 | $23,699 | $40,559 |